CCR7 belongs to the anti-tumor chemokine family, guiding dendritic cells (DCs) to migrate to lymphoid organs to initiate immune responses, activate the effector function of T cells, and exhibit anti-tumor activity (Villablanca et al., 2010). The gene discussed is CCR7; the disease is neoplasm.